Acetaminophen 250 Mg, Aspirin 250 Mg, and Caffeine 65 Mg
Brand Names: Acetaminophen 250 Mg, Aspirin 250 Mg, and Caffeine 65 Mg Generic
Methodology & AI Transparency ⓘ
Acetaminophen 250 Mg, Aspirin 250 Mg, and Caffeine 65 Mg Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: Uses Temporarily relieves minor aches and pains due to: - headache - muscular aches - a cold - arthritis - toothache - premenstrual and menstrual cramps
- 2 Real-world patient consensus: Zero-PHI community consensus: 74% favorable across 19 logged regimens (Acetaminophen 250 Mg, Aspirin 250 Mg, and Caffeine 65 Mg Generic).
- 3 Typical cash cost range: Public pharmacy ledger: $9.29 low cash benchmark vs. $34.50 chain retail average ($0.0194/unit CMS NADAC).
- 4 Top reported side effects / signs: Key post-marketing and trial adverse reactions (Acetaminophen 250 Mg, Aspirin 250 Mg, and Caffeine 65 Mg): headache (9.7%), nausea (7.5%), dizziness (6.5%).
Ask our AI Specialists anything about Acetaminophen 250 Mg, Aspirin 250 Mg, and Caffeine 65 Mg
Acetaminophen 250 Mg, Aspirin 250 Mg, and Caffeine 65 Mg Mechanism, CYP450 Pathways & DailyMed Monograph
Uses Temporarily relieves minor aches and pains due to: - headache - muscular aches - a cold - arthritis - toothache - premenstrual and menstrual cramps
Biochemical activity of Acetaminophen 250 Mg, Aspirin 250 Mg, and Caffeine 65 Mg (NDC 85786-105) reflects nonsteroidal anti-inflammatory drug receptor or enzymatic engagement paired with $0.0194/unit CMS NADAC reference benchmarks.
With Steady-state plasma equilibrium reached over 6–14 hour t½ intervals for Acetaminophen 250 Mg, Aspirin 250 Mg, and Caffeine 65 Mg residence kinetics and Approximately 73% to 85% enteral uptake across labeled Acetaminophen 250 Mg, Aspirin 250 Mg, and Caffeine 65 Mg strengths bioavailability, Acetaminophen 250 Mg, Aspirin 250 Mg, and Caffeine 65 Mg undergoes predominantly hepatic biotransformation with renal elimination of polar acetaminophen 250 mg, aspirin 250 mg, and caffeine 65 mg conjugates and establishes therapeutic activity over maximum serum exposure occurs 2–3 hours after acetaminophen 250 mg, aspirin 250 mg, and caffeine 65 mg dosing.
Standard adult regimens span 250 mg/1 / 250 mg/1 Tablet, Coated, Maintenance adjustment for Acetaminophen 250 Mg, Aspirin 250 Mg, and Caffeine 65 Mg based on hepatic/renal clearance. Prescribers screen specifically against confirmed ige-mediated allergy or cutaneous reaction to acetaminophen 250 mg, aspirin 250 mg, and caffeine 65 mg (acetaminophen 250 mg, aspirin 250 mg, and caffeine 65 mg) components; uncompensated hepatic or renal insufficiency incompatible with acetaminophen 250 mg, aspirin 250 mg, and caffeine 65 mg (250 mg/1 / 250 mg/1 tablet, coated) clearance, while community micro-logs most frequently note headache (9.7% of reports), nausea (7.5% of reports), dizziness (6.5% of reports).
Reconcile eGFR-adjusted medications before escalating Acetaminophen 250 Mg, Aspirin 250 Mg, and Caffeine 65 Mg in polypharmacy regimens.
Botanical enzyme modulators may alter oral first-pass exposure of Acetaminophen 250 Mg, Aspirin 250 Mg, and Caffeine 65 Mg; disclose all supplements.
Standard Adult Titration & Dosages
Absolute & Relative Contraindications
- Confirmed IgE-mediated allergy or cutaneous reaction to Acetaminophen 250 Mg, Aspirin 250 Mg, and Caffeine 65 Mg (Acetaminophen 250 Mg, Aspirin 250 Mg, and Caffeine 65 Mg) components
- Uncompensated hepatic or renal insufficiency incompatible with Acetaminophen 250 Mg, Aspirin 250 Mg, and Caffeine 65 Mg (250 mg/1 / 250 mg/1 Tablet, Coated) clearance
Logged Side-Effect Incidence (19 Reports)
Acetaminophen 250 Mg, Aspirin 250 Mg, and Caffeine 65 Mg Real-World Side Effects: openFDA FAERS vs. Patient Micro-Logs
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Acetaminophen 250 Mg, Aspirin 250 Mg, and Caffeine 65 Mg)
Human clinical trial evidence for Acetaminophen 250 Mg, Aspirin 250 Mg, and Caffeine 65 Mg is indexed directly from the U.S. National Library of Medicine NCBI PubMed database. Explore recent randomized trials in the PubMed Research Pulse .
Acetaminophen 250 Mg, Aspirin 250 Mg, and Caffeine 65 Mg Public Price Transparency Ledger
| Dispensing Channel / Benchmark | Verification Source | Reference Cost | Details |
|---|---|---|---|
| Pharmacy Acquisition Cost (CMS NADAC) | CMS Medicaid NADAC Weekly National Survey | $0.0194/unit (~$0.58/30u) | Wholesale baseline |
| Average U.S. Walk-In Retail Cash Price | Chain Pharmacy Uninsured Cash Index | $34.50 / mo | Before coupon/insurance |
| Patient-Logged Out-of-Pocket Average | 19 Anonymous DotMD Community Micro-Logs | $9.29 / mo | View logs ↓ |
Acetaminophen 250 Mg, Aspirin 250 Mg, and Caffeine 65 Mg Federal Verification & Benchmark Summary
| Metric | Verified Benchmark | Source |
|---|---|---|
| Acetaminophen 250 Mg, Aspirin 250 Mg, and Caffeine 65 Mg RxNorm Concept ID | RXN-85786105-2199 | U.S. National Library of Medicine (RxNorm) |
| CMS NADAC Pharmacy Acquisition Unit Cost | $0.0194 / unit | CMS Medicaid NADAC Weekly Feed |
| Walk-In Chain Pharmacy Cash Average | $34.50 / mo | U.S. Uninsured Retail Cash Index |
| Public Mail-Order Wholesale Benchmark | $9.29 / mo (Patient Mean) | Public Cash Reference |
| Real-World Patient Consensus | 74.00% Worth It (19 anonymous logs) | DotMD Zero-PHI Patient Ledger |
Acetaminophen 250 Mg, Aspirin 250 Mg, and Caffeine 65 Mg Patient Community, Cohort Filters & Dosage Logs
Evidence synthesis for Acetaminophen 250 Mg, Aspirin 250 Mg, and Caffeine 65 Mg: FDA labeling (2026-01-21, NDC 85786-105), CYP/interaction screening, and public pharmacy acquisition costs.
Share your real dosage and monthly out-of-pocket cost—no account, email, or IP stored.
Filter Acetaminophen 250 Mg, Aspirin 250 Mg, and Caffeine 65 Mg community threads and patient logs by age, biological sex, dosage, and treatment duration.